Anti-LAMB2/ LAMS/ NPHS5 functional antibody
Anti-LAMB2/ LAMS/ NPHS5 functional antibody for cell culture, ELISA & in-vivo assay
Go to LAMB2/LAMB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)
Product information
Catalog No. | Product Name | Species Reactivity |
---|---|---|
GM-Tg-hg-SE0301-Ab-1/ GM-Tg-hg-SE0301-Ab-2 | Anti-Human LAMB2 monoclonal antibody | Human |
GM-Tg-rg-SE0301-Ab-1/ GM-Tg-rg-SE0301-Ab-2 | Anti-Rat LAMB2 monoclonal antibody | Rat |
GM-Tg-mg-SE0301-Ab-1/ GM-Tg-mg-SE0301-Ab-2 | Anti-Mouse LAMB2 monoclonal antibody | Mouse |
GM-Tg-cynog-SE0301-Ab-1/ GM-Tg-cynog-SE0301-Ab-2 | Anti-Cynomolgus/ Rhesus macaque LAMB2 monoclonal antibody | Cynomolgus/ Rhesus macaque |
GM-Tg-felg-SE0301-Ab-1/ GM-Tg-felg-SE0301-Ab-2 | Anti-Feline LAMB2 monoclonal antibody | Feline |
GM-Tg-cang-SE0301-Ab-1/ GM-Tg-cang-SE0301-Ab-2 | Anti-Canine LAMB2 monoclonal antibody | Canine |
GM-Tg-bovg-SE0301-Ab-1/ GM-Tg-bovg-SE0301-Ab-2 | Anti-Bovine LAMB2 monoclonal antibody | Bovine |
GM-Tg-equg-SE0301-Ab-1/ GM-Tg-equg-SE0301-Ab-2 | Anti-Equine LAMB2 monoclonal antibody | Equine |
Size: 1mg | 10mg | 100mg
Product Description
Catalog No. | GM-Tg-hg-SE0301-Ab-1/ GM-Tg-hg-SE0301-Ab-2; GM-Tg-rg-SE0301-Ab-1/ GM-Tg-rg-SE0301-Ab-2; GM-Tg-mg-SE0301-Ab-1/ GM-Tg-mg-SE0301-Ab-2; GM-Tg-cynog-SE0301-Ab-1/ GM-Tg-cynog-SE0301-Ab-2; GM-Tg-felg-SE0301-Ab-1/ GM-Tg-felg-SE0301-Ab-2; GM-Tg-cang-SE0301-Ab-1/ GM-Tg-cang-SE0301-Ab-2; GM-Tg-bovg-SE0301-Ab-1/ GM-Tg-bovg-SE0301-Ab-2; GM-Tg-equg-SE0301-Ab-1/ GM-Tg-equg-SE0301-Ab-2 |
Products Name | Anti-LAMB2 monoclonal antibody |
Format | mab |
Target Name | LAMB2 |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category of antibody | FACS/Biofunctional Antibody |
Derivation (species) | Mouse |
CH1+2+3 Isotype (Receptor identification) | IgG |
Type of Light Chain (VD-LC) | N/A |
Expression platform | Mammalian Expression |
Bioactivity validation | Binding affinity is validated by ELISA with recombinant soluble protein antigen. The biofunction of antibodies are validated with in-vitro assay (IC50 or EC50 TBD). |
Tag | Fc |
Products description | Pre-made anti-LAMB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) |
Purity | Purity: ≥95% (SDS-PAGE) |
Application | Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research. |
Formulation & Reconstitution | Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4); For PSB2, reconstituted with 0.9% sodium chloride; For PBS, reconstituted with ddH2O. |
Storage | Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles. |
Reference
Data / case study
Click to get more Data / Case study about the product.
Associated products
Category | Cat No. | Products Name |
Target Antigen | GM-Tg-g-SE0301-Ag-1 | Recombinant multi-species LAMB2/ LAMS/ NPHS5 protein |
Target information
Target ID | GM-SE0301 |
Target Name | LAMB2 |
Gene ID | 3913,16779,25473,707892,476626,101082047,100053539 |
Gene Symbol and Synonyms | Lamb-2,LAMB2,LAMS,NPHS5,npht,PIERS,SLAM |
Uniprot Accession | P55268,P15800 |
Uniprot Entry Name | LAMB2_HUMAN,LAMB2_RAT |
Protein Sub-location | Secreted Protein/Potential Cytokines |
Category | |
Disease | Ovary Cancer |
Gene Ensembl | ENSG00000172037 |
Target Classification | N/A |
The target: LAMB2, gene name: LAMB2, also named as LAMS, NPHS5. Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, neurite outgrowth and metastasis. Laminins, composed of 3 non identical chains: laminin alpha, beta and gamma (formerly A, B1, and B2, respectively), form a cruciform structure consisting of 3 short arms, each formed by a different chain, and a long arm composed of all 3 chains. Each laminin chain is a multidomain protein encoded by a distinct gene. Several isoforms of each chain have been described. Different alpha, beta and gamma chain isomers combine to give rise to different heterotrimeric laminin isoforms which are designated by Arabic numerals in the order of their discovery, i.e. alpha1beta1gamma1 heterotrimer is laminin 1. The biological functions of the different chains and trimer molecules are largely unknown, but some of the chains have been shown to differ with respect to their tissue distribution, presumably reflecting diverse functions in vivo. This gene encodes the beta chain isoform laminin, beta 2. The beta 2 chain contains the 7 structural domains typical of beta chains of laminin, including the short alpha region. However, unlike beta 1 chain, beta 2 has a more restricted tissue distribution. It is enriched in the basement membrane of muscles at the neuromuscular junctions, kidney glomerulus and vascular smooth muscle. Transgenic mice in which the beta 2 chain gene was inactivated by homologous recombination, showed defects in the maturation of neuromuscular junctions and impairment of glomerular filtration. Alternative splicing involving a non consensus 5' splice site (gc) in the 5' UTR of this gene has been reported. It was suggested that inefficient splicing of this first intron, which does not change the protein sequence, results in a greater abundance of the unspliced form of the transcript than the spliced form. The full-length nature of the spliced transcript is not known. [provided by RefSeq, Aug 2011].
About Gmab
GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.